resveratrol derivatives (Sun Yat-Sen University/Guangzhou University of Traditional Chinese Medicine)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameresveratrol derivatives (Sun Yat-Sen University/Guangzhou University of Traditional Chinese Medicine)
Drug Alias Namebeta-amyloid aggregation inhibitors (Sun Yat-Sen University/Guangzhou University of Traditional Chinese Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou University Of Chinese MedicineSun Yat-Sen University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A